DSM IP ASSETS B.V. (20240263172). CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC) simplified abstract
Contents
CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC)
Organization Name
Inventor(s)
Johannes Andries Roubos of Echt (NL)
CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC) - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240263172 titled 'CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC)
Simplified Explanation: The patent application relates to a CRISPR transient expression construct (CTEC) for a genome editing system in the fields of molecular biology and cell biology.
Key Features and Innovation:
- CRISPR transient expression construct (CTEC) for genome editing
- Specific application in molecular biology and cell biology
- Enhances precision and efficiency of genome editing systems
Potential Applications: The technology can be used in research laboratories, biotechnology companies, and pharmaceutical industries for precise genome editing in various organisms.
Problems Solved: The technology addresses the challenges of achieving precise and efficient genome editing in molecular and cell biology research.
Benefits:
- Improved precision and efficiency in genome editing
- Potential for breakthrough discoveries in genetic research
- Enhanced capabilities for gene therapy and biotechnology applications
Commercial Applications: The CRISPR transient expression construct (CTEC) has significant commercial potential in the biotechnology and pharmaceutical industries for developing novel therapies and products.
Questions about CRISPR Transient Expression Construct (CTEC): 1. How does the CTEC technology improve genome editing efficiency? 2. What are the potential limitations of using CTEC in genome editing applications?
Original Abstract Submitted
the present invention relates to the field of molecular biology and cell biology. more specifically, the present invention relates to a crispr transient expression construct (ctec) for a genome editing system.
